# MMP-2 and MMP-9 Gene Polymorphisms and Serum Levels in Relation to Insulin Resistance in a Polish Cohort

**Authors:** Beata Gajewska, Mariola Śliwińska-Mossoń, Helena Moreira

PMC · DOI: 10.3390/ijms27052158 · 2026-02-25

## TL;DR

This study investigates whether genetic variations in MMP-2 and MMP-9 are linked to insulin resistance in a Polish population but finds no strong connection.

## Contribution

The study explores novel associations between MMP-2 and MMP-9 gene polymorphisms and insulin resistance in a Polish cohort.

## Key findings

- No significant associations were found between MMP-2 and MMP-9 polymorphisms and insulin resistance.
- MMP-9 showed genotype-related variation, and MMP-2 levels differed between insulin-resistant and control groups.
- Larger, multi-ethnic studies are needed to confirm these findings.

## Abstract

Insulin resistance is a vital component in the diagnosis of prediabetes. Understanding the factors that influence its development and the course of metabolic disorders should include individual genetic predispositions, which may provide insight into etiology and potential prevention strategies. In this study, we examined associations between MMP-2 −1306 C/T (rs243865) and MMP-9 −1562 C/T (rs3918242) single-nucleotide polymorphisms, serum levels of MMP-2, MMP-9 and TIMP-1, and the occurrence of insulin resistance in patients in a Polish cohort. DNA isolated from 200 unrelated individuals was studied; participants were divided into insulin-resistant and control groups based on the homeostatic model assessment criteria (HOMA-IR). Genotyping of MMP-2 −1306 C/T (rs243865) and MMP-9 −1562 C/T (rs3918242) SNPs was performed using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. Serum MMP-2, MMP-9, and TIMP-1 concentrations were measured by enzyme-linked immunosorbent assays (ELISA). No significant associations were observed between the investigated MMP-2 and MMP-9 polymorphisms or TIMP-1 concentrations and the occurrence of insulin resistance. MMP-9 exhibited genotype-related variation, and MMP-2 concentrations differed between the IR and CTR groups. No significant correlations were found between MMP-2 or MMP-9 and TIMP-1. Our data do not support a direct association between the analyzed polymorphisms and insulin resistance in this sample. The observed higher MMP-2 levels in controls warrant further study. Larger, multi-ethnic studies are required to confirm these findings.

## Linked entities

- **Genes:** MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076]
- **Diseases:** prediabetes (MONDO:0006920)

## Full-text entities

- **Genes:** TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}
- **Diseases:** metabolic disorders (MESH:D008659), Insulin Resistance (MESH:D007333), prediabetes (MESH:D011236)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** -1306 C/T, rs3918242

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12984337/full.md

---
Source: https://tomesphere.com/paper/PMC12984337